Blood Flow Restriction Training for Age-Related Sarcopenia
The Efficacy of Blood Flow Restriction Training in Elderly Patients With Sarcopenia.
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
Brief Title: Safe Exercise for Age-Related Muscle Loss in Hospitalized Seniors Summary: This study compares two exercise methods to help older hospital patients (age 65+) rebuild muscle strength after being diagnosed with sarcopenia (age-related muscle loss). We want to know if using special pressure cuffs during light exercise works better than traditional strength training alone. Who Can Join: Hospitalized seniors with stable health conditions Excludes those with severe disabilities, dementia, or certain blood circulation problems What We'll Do: 40 participants will be randomly assigned to either: Traditional Training Group: Uses weights/bands at 65-75% max capacity Arm/leg exercises 3x/week for 4 weeks Pressure Cuff Training Group: Uses special cuffs on arms/thighs during lighter exercises (20% max capacity) Same exercise frequency with controlled pressure for safety What We'll Measure: Handgrip strength (main test at 0/4/12 weeks) Walking speed, balance tests, quality of life surveys Any side effects like dizziness/nausea Safety First: Doctors will check your health before starting. Nurses will monitor every session. We use medical-grade cuffs with safe pressure limits (arm: 80-100mmHg, thigh: 150-200mmHg). You can stop anytime if uncomfortable. Why This Matters: This could help hospitalized seniors regain strength faster using gentler exercises. All activities are supervised by rehabilitation specialists at West China Hospital, with ethics committee approval (IRB number required).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2025
CompletedFirst Submitted
Initial submission to the registry
May 20, 2025
CompletedFirst Posted
Study publicly available on registry
May 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 10, 2025
CompletedMay 23, 2025
January 1, 2025
4 months
May 20, 2025
May 20, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Handgrip Strength
Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 12)
Secondary Outcomes (4)
6-Meter Walking Speed
Baseline (Week 0), Follow-up (Week 12)
Short Physical Performance Battery (SPPB)
Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 12)
Timed Up and Go Test (TUG)
Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 12)
MBI
Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 12)
Study Arms (2)
BFRT Group
EXPERIMENTAL"Blood flow restriction training with 20% 1RM loading, pneumatic cuff pressure 80-100mmHg (arms)
CRT Group
ACTIVE COMPARATORConventional resistance training at 65-75% 1RM intensity using weights/elastic bands, matched frequency/duration
Interventions
Standard progressive resistance exercise at 65-75% 1RM intensity using weights/elastic bands
Standard progressive resistance exercise at 65-75% 1RM intensity using weights/elastic bands
Eligibility Criteria
You may qualify if:
- Hospitalized patients aged ≥65 years
- Diagnosed with sarcopenia per EWGSOP2019 criteria
- Acute medical conditions stabilized for ≥4 weeks (e.g., resolved infections, controlled heart failure)
You may not qualify if:
- Severe disability (Barthel Index ≤40)
- Significant cognitive impairment (MMSE ≤18) or major psychiatric disorders (DSM-5 criteria)
- Contraindications to blood flow restriction training:
- History/predisposition to deep vein thrombosis
- Coagulopathy (INR \>1.5, platelets \<100×10⁹/L)
- Symptomatic varicose veins (CEAP class C4-C6)
- Uncontrolled hypertension (BP \>160/100 mmHg)
- Chronic lymphedema (ISL stage II-III)
- Peripheral artery disease (ABI ≤0.7)
- Active systemic infection (CRP \>10 mg/L)
- Malignancy (except non-melanoma skin cancer)
- Severe renal impairment (eGFR \<30 mL/min/1.73m²)
- Acute coronary syndrome within 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physiotherapist-in-Charge
Study Record Dates
First Submitted
May 20, 2025
First Posted
May 23, 2025
Study Start
May 1, 2025
Primary Completion
September 1, 2025
Study Completion
September 10, 2025
Last Updated
May 23, 2025
Record last verified: 2025-01